WRAL Tech Wire

Raleigh firm PRA lands clinical trial deal with Amgen

PRA has entered into a strategic partnership with Amgen to do work on a series of phase 3 studies to develop biosimilar drugs. Biosimilars are follow-on biologic drugs that are cheaper than very expensive biologic drugs.

What's on shopping list for CROs in the new year?

Partners, M&A possibilities, sites in Asia, private equity investments and more consulting expertise are appealing items on the want lists for contract research organizations.

PRA International may be nearing sale topping $1B

The Raleigh-based life science services firm is in the process of an "auction," according to The Wall Street Journal. If so, PRA would be the second regional contract research organization sold this fall. PPD is being sold for $3.9 billion.

PPD to explore 'unlocking value;' rumors send stock surging 10.3%

In a statement issued after a report about the company possibly being sold, Pharmaceutical Product Development says it management will "review" PPD's strategic plan and capital structure.

PPD shares soar 17% on sale report; PRA on block, too?

PRA International, which is based in Raleigh, and Pharmaceutical Product Development, which operates out of Wilmington, are looking for buyers, according to The Wall Street Journal.

PRA expands clinical research services in Sweden

The Raleigh-based contract research organization operates some 40 offices worldwide.

PRA International consolidates Polish operation in new office

Clinical research firm PRA International expands to New Zealand

PRA International promotes its chief operating officer to top job

Colin Shannon, a longtime executive at Pharmaceutical Product Development, will replace Terry Bieker as chief executive of PRA. Bieker, who is retiring, will remain a member of the contract research organization's board.

More growth: PRA International expands presence in Italy